Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gateways to clinical trials.

M Bayés1, X Rabasseda, J R Prous

  • 1Prous Science, S.A., Barcelona, Spain. mbayes@prous.com

Methods and Findings in Experimental and Clinical Pharmacology
|October 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A report from the World Conference on Lung Cancer (September 6-9, 2015 - Denver, Colorado, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the American Association of Urology Annual Meeting 2015 (May 15-19 - New Orleans, Louisiana, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 73rd Annual Meeting of the American Academy of Dermatology (March 20-24 - San Francisco, California, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the European Association for the Study of the Liver's 50th International Liver Congress (April 22-26 - Vienna, Austria).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the Conference on Retroviruses and Opportunistic Infections (CROI) 2015 (February 23-26--Seattle, Washington, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 2014 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting (November 14-19 - Boston, Massachusetts, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same journal

[Proceedings of the XVIII TASPE Seminar, Granada, Spain, 4-5 February 2010].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment algorithm for gastrointestinal graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Classification of chronic graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Pegfilgrastim in hematopoietic stem cell transplantation].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Allogeneic transplantation in multiple myeloma patients: results and recommendations in February 2010].

Methods and findings in experimental and clinical pharmacology·2011
See all related articles

This study reviews a comprehensive list of investigational drugs and radiopharmaceuticals, including targeted therapies and immunotherapies, for potential cancer treatment applications. The findings highlight diverse therapeutic agents under development for various oncological indications.

Area of Science:

  • Pharmacology and Toxicology
  • Oncology Drug Development
  • Radiopharmaceutical Therapy

Context:

  • The landscape of cancer therapeutics is rapidly evolving, necessitating a broad overview of emerging agents.
  • Numerous novel compounds and radiolabeled molecules are being investigated for their potential in treating various cancers.
  • Understanding the spectrum of these investigational agents is crucial for researchers and clinicians.

Purpose:

  • To compile and present a comprehensive list of investigational drugs and radiopharmaceuticals for cancer therapy.
  • To provide a foundational reference for ongoing and future research in oncological drug discovery.
  • To categorize agents based on their therapeutic modality, including targeted therapies and immunotherapies.

Summary:

Related Experiment Videos

  • The abstract lists a wide array of agents, including [111In]-DOTA-cG250, [131I]-Metuximab injection, [177Lu]-DOTA-cG250, Anatumomab mafenatox, AP-12009, BIBW-2992, Cediranib, and Ipilimumab.
  • Included are small molecules, monoclonal antibodies, radiolabeled conjugates, and other targeted agents such as Cilengitide, Enzastaurin hydrochloride, and PF-562271.
  • The compilation spans various therapeutic classes, reflecting the diverse strategies employed in modern cancer treatment research.

    • Impact:

    • Facilitates a broader understanding of the current pipeline of cancer therapeutics.
    • Serves as a resource for identifying potential therapeutic targets and drug candidates.
    • Supports the strategic planning of preclinical and clinical investigations in oncology.